Disease · HP_0010992
Trials36
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 1 more is not shown, since the checks do not confirm it.
1 to 20 of 36
Download this page as JSON| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03241342 | Study to Assess Enobosarm (GTx-024) in Postmenopausal Women With Stress Urinary Incontinence | Phase 2 | 491 | 2020-11-12 | Stress Urinary Incontinence | ENOBOSARM | Its record names the disease | ClinicalTrials.gov |
| NCT04193176 | Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042) | Phase 3 | 376 | 2023-09-22 | Chronic Cough | GEFAPIXANT | Its record names the disease | ClinicalTrials.gov |
| NCT02906683 | Exploratory Trial of TAS-303 in Female Patients With Stress Urinary Incontinence | Phase 2 | 337 | 2024-09-26 | Stress Urinary Incontinence | TAS-303 | Its record names the disease | ClinicalTrials.gov |
| NCT01893138 | Autologous Muscle Derived Cells for Female Urinary Sphincter Repair | Phase 3 | 311 | 2023-01-05 | Stress Urinary Incontinence | ILTAMIOCEL | Its record names the disease | ClinicalTrials.gov |
| NCT04171531 | Sling vs Botox for Mixed Incontinence | Phase 3 | 150 | 2025-03-20 | Urinary Incontinence, Stress, Urinary Incontinence, Urge | ONABOTULINUMTOXINA | Its record names the disease | ClinicalTrials.gov |
| NCT00904618 | Safety and Efficacy Study on the Implantation of the Tension-Free Vaginal Tape (TVT-Secur) Under Local Anesthesia | Phase 2 | 48 | 2009-05-19 | Urinary Stress Incontinence | LIDOCAINE | Its record names the disease | ClinicalTrials.gov |
| NCT01042236 | Evaluation Of The Ability Of Fesoterodine To Increase Urethral Pressure In Stress Urinary Incontinence Patients | Phase 2 | 22 | 2011-07-01 | Stress Urinary Incontinence | FESOTERODINE | Its record names the disease | ClinicalTrials.gov |
| NCT02658448 | GTx-024 as a Treatment for Stress Urinary Incontinence in Women | Phase 2 | 19 | 2021-02-01 | Stress Urinary Incontinence | ENOBOSARM | Its record names the disease | ClinicalTrials.gov |
| NCT03102645 | Does Single Dose Imipramine Affect the Opening Pressure of the Urethral and Anal Sphincter? | Phase 1 | 16 | 2021-02-12 | Urinary Incontinence, Stress, Fecal Incontinence | IMIPRAMINE HYDROCHLORIDE | Its record names the disease | ClinicalTrials.gov |
| NCT00190905 | Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions. | Phase 4 | 4,000 | Stress Urinary Incontinence | DULOXETINE | Its record names the disease | ClinicalTrials.gov | |
| NCT00190996 | Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence | Phase 3 | 2,765 | Urinary Incontinence, Stress | DULOXETINE | Its record names the disease | ClinicalTrials.gov | |
| NCT07202884 | A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight | Phase 3 | 1,000 | Urinary Incontinence,Stress | ORFORGLIPRON | Its record names the disease | ClinicalTrials.gov | |
| NCT00190632 | To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary Incontinence | Phase 3 | 600 | Stress Urinary Incontinence | DULOXETINE | Its record names the disease | ClinicalTrials.gov | |
| NCT00190645 | To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence | Phase 3 | 600 | Stress Urinary Incontinence | DULOXETINE | Its record names the disease | ClinicalTrials.gov | |
| NCT00191087 | Duloxetine in the Treatment of Stress Urinary Incontinence. | Phase 3 | 458 | Urinary Incontinence, Stress | DULOXETINE | Its record names the disease | ClinicalTrials.gov | |
| NCT00138749 | An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence. | Phase 2 | 402 | Urinary Incontinence, Stress | REBOXETINE | Its record names the disease | ClinicalTrials.gov | |
| NCT00191204 | Open Label Phase III Duloxetine Study for Stress Urinary Incontinence | Phase 3 | 363 | Urinary Incontinence Stress | DULOXETINE | Its record names the disease | ClinicalTrials.gov | |
| NCT04512053 | A Phase 2 Study of TAS-303 in Female Patients With Stress Urinary Incontinence | Phase 2 | 231 | Stress Urinary Incontinence | TAS-303 | Its record names the disease | ClinicalTrials.gov | |
| NCT00190606 | Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary Incontinence | Phase 2 | 200 | Urinary Stress Incontinence | DULOXETINE | Its record names the disease | ClinicalTrials.gov | |
| NCT00475358 | Efficacy and Safety Stress Urinary Incontinence Study | Phase 3 | 120 | Urinary Incontinence, Stress | DULOXETINE | Its record names the disease | ClinicalTrials.gov |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/HP_0010992/trials